The Infectious Diseases Society of America’s podcast features discussions with experts on a range of topics related to infectious diseases including antimicrobial resistance, ID diagnostics and outbreaks such as COVID-19, Ebola and measles. Episodes on IDSA’s guidelines are also available.
The Latest on Long COVID (April 23, 2022)
Dr. Kathleen Bell, Professor and Chair of the Department of Physical Medicine and Rehabilitation at UT Southwestern Medical Center, and Dr. Nahid Bhadelia, associate professor of infectious diseases at Boston University School of Medicine and founding director of the BU Center of Emerging Infectious Diseases Policy and Research, discuss the latest research and information on long COVID.
Cultural Awareness Series: Representation of Women in Medicine and Overcoming Barriers of Advancement
In this rebroadcast of the COVID-19 Real-Time Learning Network’s Cultural Awareness Series, Gayathri Krishnan, MBBS, MD, Arghavan Salles, MD, PhD, and Laila Woc-Colburn, MD, DTM&H, FIDSA and moderator Mati Hlatshwayo Davis, MD, MPH discuss the representation of women in medicine, the impact the pandemic has had on women in the workforce and overcoming barriers to advancement.
Let's Talk ID: A Conversation with CDC Director Rochelle P. Walensky, MD, MPH, FIDSA
IDSA President Daniel McQuillen, MD, FIDSA is joined by CDC Director Rochelle P. Walensky, MD, MPH, FIDSA to discuss the current state of the COVID-19 pandemic and the pivotal role of infectious disease physicians.
COVID-19 Vaccines & Prevention in Immunocompromised individuals
IDSA members Archana Chatterjee, MD, FIDSA of Rosalind Franklin University and Myron Cohen, MD, FIDSA of UNC Chapel Hill share insight on COVID-19 vaccines and prevention in immunocompromised individuals, including current recommendations and the role of antibody testing.
The Latest on COVID-19 Treatments (March 12, 2022)
IDSA COVID-19 Guidelines co-authors Rajesh Gandhi, MD, FIDSA and Adarsh Bhimraj, MD, FIDSA provide the latest information on COVID-19 treatments, including the potential role of combination therapies, newer therapies such as nirmatrelvir and strovimab, and their thoughts on President Biden's "Test to Treat" initiative.
Let's Talk ID - Investing in the Future of ID
Last fall, the IDSA Board of Directors took a fresh look at IDSA’s strategic plan, understanding that now is the time to seize the moment as the important contributions of the ID workforce during the pandemic are front and center. In this episode, IDSA President Daniel McQuillen, MD, FIDSA, IDSA Vice President Steven Schmitt, MD, FIDSA of the Cleveland Clinic, IDSA Treasurer Jeanne Marrazzo, MD, FIDSA of the University of Alabama at Birmingham and IDSA AMR Committee Chair Emily Spivak, MD, FIDSA of the University of Utah discuss three initiatives in which the Board approved significant investments and how they will positively impact the field of ID.
Separation of positive kids from parents
Parents are fearful to have their children tested for covid because they may be separated from their parents.
Biased. Most do not read the data to really provide appropriate recommendations. Very generalized statements. I’m disappointed.
Useful, good format
I think the question and answer format is good. I think mentioning the strength of recommendation would be useful but these are available in the written guidelines.